Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

National Infection and Sepsis Audit – Acute NHS settings

Healthcare Quality Improvement Partnership · Tender notice on Find a Tender

Tender information last checkedLast checked 20 Sept 2026, 07:38.

Opportunity overview

The contract for the Infection and Sepsis Audit - Acute care settings (NISA-Acute) will initially be delivered for NHS-funded care in England and Wales for a period of three years, at a maximum total budget of up to £ 1,146,300.00 excl VAT and £1,375,560.00 with VAT. Bids exceeding these limits will be rejected. All pricing submissions must be in regard to this 'core' value, and not inclusive of any extension costs or aspirational intent costs, i.e. Please only submit a cost schedule up to the maximum core value of £ 1,146,300.00 excl VAT and £1,375,560.00 with VAT. The maximum budget ‘core’ value excludes the potential two year extension and aspirational intent as described in section 14.3 of Annex A - Service Specification. Please note, there is no commitment by the Authority at this stage to include any of the below aspirational intent. Taking this aspirational intent into account, including the possibility that a contract extension may be offered for an additional 24 months, the potential ceiling value is £8,988,606.00 GBP including VAT. This is a new national clinical audit for severe infection and sepsis in acute NHS hospital settings. The aim is to provide benchmarked infection and sepsis care data to identify variation and drive improvement over time. Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. While it is an unusual complication of developing an infection, it can be triggered by any infection. When people die from an infection, it is most commonly due to sepsis. Sepsis is complex and hard to diagnose, with no single test and symptoms that overlap with other conditions (NHS England Modern Service Framework, 2026) Severe infections may lead to the development of sepsis, particularly in at-risk groups, and are one of the most common reasons for emergency admission to hospital. Both infection and sepsis are major causes of morbidity and mortality in the UK, and costly to the NHS and wider economy: In 2025 there were over 23,000 deaths involving sepsis (Office for National Statistics). Patients and carers who we engaged with as part of specification development told us of long-term impacts that some sepsis survivors experience, from reduced mobility and cognitive difficulties, to loss of limbs or vision impairments. Each year, the NHS in England spends over £1billion on sepsis care, and over £6.5billion on infection care. Wider economic costs are estimated at £10-15billion annually (York Health Economics Consortium, 2017). 1,300 clinical negligence claims were made regarding sepsis from 2020/21 to 2024/25, costing £65.3m in litigation. Most claims relate to delays and failures in treatment and diagnosis. Several major healthcare initiatives have been launched to help improve care related to sepsis and severe infection, including: NHS England’s sepsis Modern Service Framework (MSF), which aims to reduce death, life-threatening complications and long-term impact from sepsis and severe infection by at least 25% by 2035, as well as reducing health inequalities (published July 2026). NHS England’s National Improvement Programme for ‘Optimising the acute management of sepsis’ (as part of the MSF activities). The National Patient Safety Plan for NHS Wales 2026-2031, which includes sepsis care. The UK Anti-Microbial Resistance (AMR) National Action Plan, which pledges to strengthen infection prevention and control (IPC) and antimicrobial stewardship (AMS) in health and social care settings New NICE guidelines for recognition, diagnosis and early management of suspected sepsis, published in November 2025 (NG253-NG255) Establishing the NISA-Acute audit is a key ambition of the NHS England sepsis MSF, and the audit will be expected to align closely with all the initiatives listed above. The audit funders have selected ‘early stages of care’ as the initial priority for this audit because this is a critical point for effective severe infection management and the swift identification and treatment of sepsis. Prompt, effective treatment is vital to improving outcomes, and both Prevention of Future Death (PFD) reports and Health Services Safety Investigations Body (HSSIB) investigations have highlighted opportunities to improve care in this area.

Classification

  • CPV85100000 — Health services

Lots

  • Lot 1£7.5m

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
1025879250
Status
active
Procurement Method
open
Procurement Method Details
Open procedure
Main Procurement Category
services
Above Threshold
Yes
Published risks
Full descriptive details of these measures, as well as the mechanisms for invoking them can be found in section 14.3 of Annex A - Service Specification. All figures are inclusive of VAT: 1. Up to 24-month extension that mirrors the NCAPOP headline contract (Please refer to Annex J - NHSE_HQIP NCAPOP Contract REDACTED) - up to £917,040.00 2. Expansion of the scope of the NISA-Acute audit and/or addition of further workstreams, e.g. to cover more patients or other aspects of patient care (the list below is not intended to be exhaustive)up to £2,1600,000.00 3. Addition of patient reported outcome measure (PROM) or patient reported experience measure (PREM) Up to £600,000.00 4. Transition to different models of data collection/outputs &/or operational methods/processes for the audit. This may include implementing new ways of working where opportunities emerge to leverage artificial intelligence tools to drive efficiency and reduce burden up to £631,080.00. 5. Extending specific service coverage to include privately funded care up to £360,000.00 6. Additions or enhancements to the service delivery of the project up to £1,200,000.00 7.Additional quality improvement initiatives either related to or linked with the project up to £720,000.00

Legal basis

Id
2023/54
Scheme
UKPGA

Submission terms

Electronic Submission Policy
allowed

Languages

en

Tender Period

Ends
27 Oct 2026, 12:00

Enquiry period

Ends
12 Oct 2026, 12:00

Expected award period

Ends
14 Jan 2027, 23:59

Contract terms

Financial Terms
Payment will be made quarterly in arrears as described in the provider terms (Annex B). Disputed invoices will be dealt with as described in the provider terms (Annex B)

Lots and requirements

Entry 1
Id
1
Status
active
Has Renewal
Yes

Value

Including VAT
8,988,606
Amount
7,490,505
Currency
GBP

Award criteria

Criteria

Criterion 1
Type
quality
Name
LEADERSHIP
Description
See ITT

Numbers

Entry 1
Number
5
Weight
percentageExact
Criterion 2
Type
quality
Name
ENGAGING AND INVOLVING PATIENTS, CARERS AND THE PUBLIC
Description
See ITT

Numbers

Entry 1
Number
8
Weight
percentageExact
Criterion 3
Type
quality
Name
SUPPORTING HEALTHCARE QUALITY IMPROVEMENT
Description
See ITT

Numbers

Entry 1
Number
8
Weight
percentageExact
Criterion 4
Type
quality
Name
HEALTHCARE PROVIDER ENGAGEMENT, PARTICIPATION AND SUPPORT
Description
See ITT

Numbers

Entry 1
Number
8
Weight
percentageExact
Criterion 5
Type
quality
Name
DATA ACQUISITION STRATEGY AND BURDEN
Description
See ITT

Numbers

Entry 1
Number
12
Weight
percentageExact
Criterion 6
Type
quality
Name
INFORMATION GOVERNANCE
Description
See ITT

Numbers

Entry 1
Number
4
Weight
percentageExact
Criterion 7
Type
quality
Name
DATA QUALITY ANALYSIS
Description
See ITT

Numbers

Entry 1
Number
12
Weight
percentageExact
Criterion 8
Type
quality
Name
USES OF THE DATA
Description
See ITT

Numbers

Entry 1
Number
12
Weight
percentageExact
Criterion 9
Type
quality
Name
PROGRAMME GOVERNANCE AND DELIVERY PLAN
Description
See ITT

Numbers

Entry 1
Number
12
Weight
percentageExact
Criterion 10
Type
quality
Name
RISK MANAGEMENT
Description
See ITT

Numbers

Entry 1
Number
4
Weight
percentageExact
Criterion 11
Type
price
Name
COST & ALLOCATION OF BUDGET
Description
See ITT

Numbers

Entry 1
Number
5
Weight
percentageExact
Criterion 12
Type
quality
Name
SOCIAL VALUE
Description
See ITT

Numbers

Entry 1
Number
10
Weight
percentageExact

Suitability

Sme
Yes
Vcse
Yes

Contract period

Starts
1 Apr 2027, 00:00
Ends
30 Mar 2030, 23:59
Max Extent Date
30 Mar 2032, 23:59

Renewal

Description
Up to 2 years extension. A 5 year contract in total

Items and delivery

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
85100000
Description
Health services

Delivery locations

Entry 1
Region
UK
Country
GB
Country Name
United Kingdom

Published documents

Entry 1
Id
conflictOfInterest
Document Type
conflictOfInterest
Description
Not published
Entry 2
Id
088832-2026
Document Type
tenderNotice
Notice Type
UK4
Description
Tender notice on Find a Tender
Published
18 Sept 2026, 15:46
Format
text/html

Buyer, suppliers and contacts

Organisation 1
Name
Healthcare Quality Improvement Partnership
Id
GB-PPON-PVVQ-6113-CJWD

Identifier

Scheme
GB-PPON
Id
PVVQ-6113-CJWD

Address

Street Address
c/o Buzzacott LLP
Locality
London
Postal Code
EC2V 6DL
Country
GB
Country Name
United Kingdom
Region
UKI31

Contact

Name
Judith Hughes

Roles

buyer

Details

Classifications

Entry 1
Scheme
UK_CA_TYPE
Id
publicAuthoritySubCentralGovernment
Description
Public authority - sub-central government

Recorded locations

  • Buyer location · London · UKI31 · EC2V 6DL · United Kingdom
  • Delivery location · UK · United Kingdom

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. 088832-2026Tender notice on Find a Tender ·